You just read:

Emmaus Life Sciences to Present Abstract of Completed Phase 3 Sickle Cell Disease Trial at 9th Annual Sickle Cell and Thalassaemia Advanced Conference in London

News provided by

Emmaus Life Sciences, Inc.

06 Oct, 2015, 11:00 BST